Clinical trial
A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or…
NCT00436423 · Korea University Anam Hospital, Other · Completed
Key facts
| NCT number | NCT00436423 |
|---|---|
| Title | A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer |
| Lead sponsor | Korea University Anam Hospital, Other |
| Collaborators | Seoul National University Hospital Seoul Municipal Boramae Hospital Konkuk University Hospital Korea University Ansan Hospital Seoul National University Bundang Hospital Korea University Guro Hospital |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | gemcitabine, TS-1 |
| Enrollment | 38 |
| Start date | Mar 1, 2006 |
| First posted | Feb 19, 2007 |
| Last update posted | Nov 1, 2007 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: